Copyright
©2012 Baishideng Publishing Group Co.
World J Gastroenterol. Jan 28, 2012; 18(4): 349-355
Published online Jan 28, 2012. doi: 10.3748/wjg.v18.i4.349
Published online Jan 28, 2012. doi: 10.3748/wjg.v18.i4.349
Figure 1 Expression and identification of the Ad315-preS2Ab-mediated preS2Ab.
A: ELISA results show that the expression levels of the preS2Ab increase in the supernatants of Ad315-preS2Ab-infected L02 cells with increases in MOI; B: Western blotting shows that the expression of preS2Ab is high at an MOI of 100 pfu/cell. GAPDH is used as the loading control; C: The expressed preS2Ab in the supernatant of Ad315-preS2Ab-infected L02 cells recognizes liver cells from HBV transgenic Imprinting Control Region (ICR) mice as shown by a strong immunofluorescent reaction (left). Liver cells of normal ICR mice do not show labeling (right) (× 200). ELISA: Enzyme linked immunosorbent assay; HBV: Hepatitis B virus; GAPDH: Glyceraldehyde-3-phosphate dehydrogenase; MOI: Multiplicity of infection.
- Citation: Zhang Q, Li ZQ, Liu H, Yang JH. Adenovirus-expressed preS2 antibody inhibits hepatitis B virus infection and hepatic carcinogenesis. World J Gastroenterol 2012; 18(4): 349-355
- URL: https://www.wjgnet.com/1007-9327/full/v18/i4/349.htm
- DOI: https://dx.doi.org/10.3748/wjg.v18.i4.349